We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Patient Navigation to Improve Early Access to Supportive Care for Patients with Advanced Cancer in Resource‐Limited Settings: A Randomized Controlled Trial.
- Authors
Soto‐Perez‐de‐Celis, Enrique; Chavarri‐Guerra, Yanin; Ramos‐Lopez, Wendy Alicia; Alcalde‐Castro, Jacqueline; Covarrubias‐Gomez, Alfredo; Navarro‐Lara, África; Quiroz‐Friedman, Paulina; Sánchez‐Román, Sofía; Alcocer‐Castillejos, Natasha; Aguilar‐Velazco, José Carlos; Bukowski, Alexandra; Chávarri‐Maldonado, Juan Alberto; Contreras‐Garduño, Sergio; Krush, Lindsay; Inoyo, Itoro; Medina‐Campos, Andrea; Moreno‐García, María Luisa; Perez‐Montessoro, Viridiana; Bourlon, María T.; Peña‐Lopez, Roberto
- Abstract
Background: The early integration of supportive care in oncology improves patient‐centered outcomes. However, data are lacking regarding how to achieve this in resource‐limited settings. We studied whether patient navigation increased access to multidisciplinary supportive care among Mexican patients with advanced cancer. Materials and Methods: This randomized controlled trial was conducted between August 2017 and April 2018 at a public hospital in Mexico City. Patients aged ≥18 years with metastatic tumors ≤6 weeks from diagnosis were randomized (1:1) to a patient navigation intervention or usual care. Patients randomized to patient navigation received personalized supportive care from a navigator and a multidisciplinary team. Patients randomized to usual care obtained supportive care referrals from treating oncologists. The primary outcome was the implementation of supportive care interventions at 12 weeks. Secondary outcomes included advance directive completion, supportive care needs, and quality of life. Results: One hundred thirty‐four patients were randomized: 67 to patient navigation and 67 to usual care. Supportive care interventions were provided to 74% of patients in the patient navigation arm versus 24% in usual care (difference 0.50, 95% confidence interval [CI] 0.34–0.62; p <.0001). In the patient navigation arm, 48% of eligible patients completed advance directives, compared with 0% in usual care (p <.0001). At 12 weeks, patients randomized to patient navigation had less moderate/severe pain (10% vs. 33%; difference 0.23, 95% CI 0.07–0.38; p =.006), without differences in quality of life between arms. Conclusion: Patient navigation improves access to early supportive care, advance care planning, and pain for patients with advanced cancer in resource‐limited settings. Implications for Practice: The early implementation of supportive care in oncology is recommended by international guidelines, but this might be difficult to achieve in resource‐limited settings. This randomized clinical trial including 134 Mexican patients with advanced cancer demonstrates that a multidisciplinary patient navigation intervention can improve the early access to supportive and palliative care interventions, increase advance care planning, and reduce symptoms compared with usual oncologist‐guided care alone. These results demonstrate that patient navigation represents a potentially useful solution to achieve the adequate implementation of supportive and palliative care in resource‐limited settings globally. Patient navigation assists patients in overcoming barriers to care, but its use is under‐used in resource‐limited settings. This article examines whether a patient navigator‐led intervention could improve early access to multidisciplinary supportive and palliative care among Mexican patients with metastatic solid tumors.
- Subjects
MEXICO; TUMOR treatment; CANCER patients; CANCER patient medical care; COMPARATIVE studies; CONFIDENCE intervals; HEALTH care teams; HEALTH services accessibility; PALLIATIVE treatment; QUALITY of life; ADVANCE directives (Medical care); SOCIAL support; RANDOMIZED controlled trials; PATIENT-centered care; EARLY medical intervention; DESCRIPTIVE statistics
- Publication
Oncologist, 2021, Vol 26, Issue 2, p157
- ISSN
1083-7159
- Publication type
Article
- DOI
10.1002/onco.13599